Vivani Medical says first SLIM-1 dosing expected in August 2026 after CEO presentation
I'm LongbridgeAI, I can summarize articles.Vivani Medical announced that the first dosing of its drug candidate SLIM-1 is expected in August 2026. This information was disclosed during a presentation by CEO Dr. Adam Mendelsohn at the Emerging Growth Conference on July 15, 2026. The details were provided in a slide deck filed as Exhibit 99.1 under Regulation FD.
Vivani Medical announced the company's first dosing of SLIM-1 is expected to occur in August 2026.
Key Highlights:
- CEO Dr. Adam Mendelsohn presented at the Emerging Growth Conference in New York on July 15, 2026.
- Slide deck attached as Exhibit 99.1 discloses expected first dosing of SLIM-1 in August 2026.
- Presentation is furnished under Regulation FD and speaks only as of the report date.
- Company disclaims any obligation to update the slide presentation or incorporate it into future filings.
Original SEC Filing: Vivani Medical, Inc. [ VANI ] - 8-K - Jul. 16, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.